KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 252 filers reported holding KITE PHARMA INC in Q3 2017. The put-call ratio across all filers is 1.40 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $6,059,000 | +26.3% | 58,443 | -4.3% | 0.09% | +13.6% |
| Q1 2017 | $4,796,000 | +67.4% | 61,100 | -4.4% | 0.08% | +47.3% |
| Q4 2016 | $2,865,000 | -29.7% | 63,904 | -12.5% | 0.06% | -23.6% |
| Q3 2016 | $4,078,000 | +73.5% | 73,000 | +55.3% | 0.07% | +60.0% |
| Q2 2016 | $2,350,000 | +8.9% | 47,000 | 0.0% | 0.04% | +7.1% |
| Q1 2016 | $2,158,000 | -25.5% | 47,000 | 0.0% | 0.04% | -17.6% |
| Q4 2015 | $2,896,000 | +10.7% | 47,000 | 0.0% | 0.05% | +15.9% |
| Q3 2015 | $2,617,000 | -14.1% | 47,000 | -6.0% | 0.04% | +100.0% |
| Q2 2015 | $3,048,000 | +45.2% | 50,000 | +42.9% | 0.02% | -26.7% |
| Q1 2015 | $2,099,000 | – | 35,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|